Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesNew acute and chronic black holes in multiple sclerosis patients randomized to interferon beta-1b or glatiramer acetate
Journal of Neurology, Neurosurgery, and Psychiatry , 08/26/09
Cadavid D et al. – Only a minority of new brain lesions in MS patients treated with GA or IFN–beta–1b convert to CBH.
Related Articles
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial : The Lancet
The Lancet - Early Online Publication, 10/08/09
Relevance Score: 70%
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
The Lancet, 11/03/09
Relevance Score: 66%
Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate
Proceedings of the National Academy of Sciences of the United States of America, 10/23/09
Relevance Score: 66%
Early Drug Treatment May Cut Multiple Sclerosis Risk
MedLinePlus, 10/08/09
Relevance Score: 64%
Serum levels of CXCL13 are elevated in active multiple sclerosis
Multiple Sclerosis, 10/08/09
Relevance Score: 64%
Today in Demyelinating Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Chronic inflammatory demyelinating polyradiculoneuropathy in children: characterized by subacute, predominantly motor dominant polyeuropathy with a favorable response to the treatment
Acta Neurologica Scandinavica, 12/15/09
Large scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis
Journal of Neurology, Neurosurgery, and Psychiatry , 12/15/09
Sponsor
Article Search
Sponsor
Sponsor